In last trading session, Procept BioRobotics Corp (NASDAQ:PRCT) saw 0.79 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price level of $76.60 trading at $0.25 or 0.33% at ring of the bell on the day assigns it a market valuation of $3.98B. That closing price of PRCT’s stock is at a discount of -12.02% from its 52-week high price of $85.81 and is indicating a premium of 67.58% from its 52-week low price of $24.83. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.66 million shares which gives us an average trading volume of 663.91K if we extend that period to 3-months.
For Procept BioRobotics Corp (PRCT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.22. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ:PRCT) trade information
Upright in the green during last session for gaining 0.33%, in the last five days PRCT remained trading in the red while hitting it’s week-highest on Friday, 08/30/24 when the stock touched $76.60 price level, adding 5.36% to its value on the day. Procept BioRobotics Corp’s shares saw a change of 82.77% in year-to-date performance and have moved -2.66% in past 5-day. Procept BioRobotics Corp (NASDAQ:PRCT) showed a performance of 27.52% in past 30-days. Number of shares sold short was 5.67 million shares which calculate 8.8 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 75 to the stock, which implies a fall of -2.13% to its current value. Analysts have been projecting 49 as a low price target for the stock while placing it at a high target of 95. It follows that stock’s current price would jump 36.03% in reaching the projected high whereas dropping to the targeted low would mean a gain of 36.03% for stock’s current value.
Procept BioRobotics Corp (PRCT) estimates and forecasts
Statistics highlight that Procept BioRobotics Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 55.44% of value to its shares in past 6 months, showing an annual growth rate of 16.07% while that of industry is 12.90. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -23.27% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 15.76% while estimates for its earnings growth in next 5 years are of 23.10%.
Procept BioRobotics Corp (NASDAQ:PRCT)’s Major holders
Insiders are in possession of 5.05% of company’s total shares while institution are holding 87.99 percent of that, with stock having share float percentage of 92.66%. Investors also watch the number of corporate investors in a company very closely, which is 87.99% institutions for Procept BioRobotics Corp that are currently holding shares of the company. FMR LLC is the top institutional holder at PRCT for having 7.29 million shares of worth $445.33 million. And as of 2024-06-30, it was holding 14.2907 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.71 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2375 of outstanding shares, having a total worth of $287.87 million.
On the other hand, Vanguard Total Stock Market Index Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024 , the former fund manager was holding 1.56 shares of worth $119.63 million or 3.01% of the total outstanding shares. The later fund manager was in possession of 1.24 shares on Jul 31, 2024 , making its stake of worth around $95.24 million in the company or a holder of 2.39% of company’s stock.
